ChiCTR2200063160 版本V1.1 版本创建时间2023/04/05 20:38:55 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200063160 

最近更新日期:

Date of Last Refreshed on:

2022-09-01 17:20:39 

注册时间:

Date of Registration:

2022-09-01 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

认知储备与痴呆临床前期(主观认知下降、轻度认知障碍)患者认知功能纵向变化的关系:一项队列研究

Public title:

Relationship between cognitive reserve and longitudinal changes in cognitive function in patients with preclinical dementia (subjective cognitive decline, mild cognitive impairment): a cohort study

注册题目简写:

认知储备与痴呆临床前期患者认知功能纵向变化的关系

English Acronym:

Relationship between cognitive reserve and longitudinal changes in cognitive function in patients with preclinical dementia

研究课题的正式科学名称:

认知储备与痴呆临床前期(主观认知下降、轻度认知障碍)患者认知功能纵向变化的关系:一项队列研究

Scientific title:

Relationship between cognitive reserve and longitudinal changes in cognitive function in patients with preclinical dementia (subjective cognitive decline, mild cognitive impairment): a cohort study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

钟瑭盛 

研究负责人:

陈立 

Applicant:

tangsheng zhong 

Study leader:

Li Chen 

申请注册联系人电话:

Applicant telephone:

+86 13689811915

研究负责人电话:

Study leader's
telephone:

0431-85619366

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zhongtangsheng@jlu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

chenl@jlu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

吉林省长春市朝阳区新疆街965号护理学院

研究负责人通讯地址:

吉林省长春市朝阳区新疆街965号护理学院

Applicant address:

965 Xinjiang Street, Chaoyang District, Changchun, Jilin

Study leader's address:

965 Xinjiang Street, Chaoyang District, Changchun, Jilin

申请注册联系人邮政编码:

Applicant postcode:

130021

研究负责人邮政编码:

Study leader's postcode:

130021

申请人所在单位:

吉林大学第一医院

Applicant's institution:

The First Hospital of Jilin University

研究负责人所在单位:

吉林大学护理学院

Affiliation of the Leader:

School of Nursing, Jilin University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2022083102

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

吉林大学护理学院伦理委员会

Name of the ethic committee:

Ethics Committee of Jilin University School of Nursing

伦理委员会批准日期:

Date of approved by ethic committee:

2022-08-31 00:00:00

伦理委员会联系人:

李峰

Contact Name of the ethic committee:

Feng Li

伦理委员会联系地址:

吉林省长春市朝阳区新疆街965号护理学院

Contact Address of the ethic committee:

965 Xinjiang Street, Chaoyang District, Changchun, Jilin

伦理委员会联系人电话:

Contact phone of the ethic committee:

0431-85619377

伦理委员会联系人邮箱:

Contact email of the ethic committee:

fengl@jlu.edu.cn

研究实施负责(组长)单位:

吉林大学护理学院

Primary sponsor:

School of Nursing, Jilin University

研究实施负责(组长)单位地址:

吉林省长春市朝阳区新疆街965号护理学院

Primary sponsor's address:

965 Xinjiang Street, Chaoyang District, Changchun, Jilin

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

吉林

市(区县):

长春

Country:

China

Province:

Jilin

City:

Changchun

单位(医院):

吉林大学护理学院

具体地址:

朝阳区新疆街965号

Institution
hospital:

Jilin University School of Nursing

Address:

965 Xinjiang Street, Chaoyang District

经费或物资来源:

博士生培养经费

Source(s) of funding:

Ph.D. Training Funds

研究疾病:

主观认知下降  

Target disease:

subjective cognitive decline

研究疾病代码:

6D71

Target disease code:

6D71

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

探讨认知储备和AD临床前期人群纵向认知功能的关系  

Objectives of Study:

To explore the relationship between cognitive reserve and longitudinal cognitive function in pre-AD population

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①年龄≥50岁;②符合前述的SCD、MCI诊断标准;③视听能力正常,无沟通障碍;③本市生活,未来一年没有搬迁计划;④自愿参加本次研究,并同意接受规律的复查和随访。

Inclusion criteria

①Age ≥60 years old; ②Meet the above-mentioned SCD or MCI diagnostic criteria; ③Normal audio-visual ability, no communication barriers; ③Living in the city, no relocation plan in the next year; ④Voluntarily participate in this study, and agree to receive regular review and follow-up .

排除标准:

①严重头部损伤或颅内病变,或患有其他神经疾病(如帕金森、中风、多发性硬化症等);②严重精神障碍者;③第一轮随访失访,关键预测信息丢失;

Exclusion criteria:

①Severe head injury or intracranial lesions, or suffering from other neurological diseases (such as Parkinson's, stroke, multiple sclerosis, etc.); ②Severe mental disorders; ③The first round of follow-up was lost, and key predictive information was lost;

研究实施时间:

Study execute time:

From 2022-09-01 00:00:00 To 2024-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-09-05 00:00:00 To 2022-12-31 00:00:00

干预措施:

Interventions:

组别:

暴露组

样本量:

112

Group:

Exposure group

Sample size:

干预措施:

干预措施代码:

Intervention:

NA

Intervention code:

组别:

非暴露组

样本量:

112

Group:

Non-exposed group

Sample size:

干预措施:

干预措施代码:

Intervention:

NA

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

吉林 

市(区县):

长春 

Country:

China

Province:

Jilin

City:

Changchun

单位(医院):

吉林大学第一医院 

单位级别:

三级甲等 

Institution
hospital:

The First Hospital of Jilin University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

认知储备量表

指标类型:

主要指标

Outcome:

Cognitive Reserve Scale

Type:

Primary indicator

测量时间点:

进入队列后第1、3、6个月,之后是每6个月

测量方法:

Measure time point of outcome:

1st, 3rd, 6th months after entering the cohort, then every 6 months

Measure method:

指标中文名:

蒙特利尔认知评估表

指标类型:

主要指标

Outcome:

Montreal Cognitive Assessment (MoCA)

Type:

Primary indicator

测量时间点:

进入队列后第1、3、6个月,之后是每6个月

测量方法:

Measure time point of outcome:

1st, 3rd, 6th months after entering the cohort, then every 6 months

Measure method:

指标中文名:

身体质量指数

指标类型:

主要指标

Outcome:

Body Mass Index(BMI)

Type:

Primary indicator

测量时间点:

进入队列后第1、3、6个月,之后是每6个月

测量方法:

Measure time point of outcome:

1st, 3rd, 6th months after entering the cohort, then every 6 months

Measure method:

指标中文名:

头部核磁

指标类型:

主要指标

Outcome:

Head MRI

Type:

Primary indicator

测量时间点:

进入队列后每6个月

测量方法:

Measure time point of outcome:

Every 6 months after entering the cohort

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

静脉

Sample Name:

blood

Tissue:

vein

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 50 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

队列研究(观察性研究),未做随机化

Randomization Procedure (please state who generates the random number sequence and by what method):

Cohort study (observational study), not randomized

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

网络平台http://www.pkudata.cn/

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Network platform http://www.pkudata.cn/

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用病例记录表(Case Record Form, CRF)收集数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Use Case Record Form (CRF) to collect data

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-09-01 17:20:29